![Jonathan Neely](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Neely
Investor Relations Contact at
OPTINOSEPAR
Profile
Mr. Jonathan Neely is an Investor Relations Contact at DBV Technologies SA and a VP-Investor Relations & Business Development at OptiNose, Inc. Mr. Neely was previously employed as a Head-Investor Relations & Corporate Communications by Axovant Sciences, Inc. and a Director-Financial, Planning, Analysis & IR by Endo LP.
He received his undergraduate degree from the University of Pittsburgh and a graduate degree from the University of Pittsburgh.
Jonathan Neely active positions
| Companies | Position | Start |
|---|---|---|
| OPTINOSEPAR | Investor Relations Contact | 01/08/2020 |
| DBV TECHNOLOGIES | Investor Relations Contact | 01/12/2025 |
Former positions of Jonathan Neely
| Companies | Position | End |
|---|---|---|
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Investor Relations Contact | 01/10/2017 |
| ENDO, INC. | Director of Finance/CFO | - |
Education of Jonathan Neely
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
Endo, Inc.
 Endo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures branded and generic pharmaceuticals & sterile injectables | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Jonathan Neely
